TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Monash University-led study across 31 Australian general practices found that a 12-month nurse-led program improved estimated dementia risk scores among adults aged 45 to 65 with modifiable risk factors. The study measured changes in risk profiles, not dementia diagnoses or prevention; researchers say 36-month follow-up will help show whether the changes last.
A Monash University-led trial found that a 12-month program delivered by general practice nurses improved estimated dementia risk profiles among adults aged 45 to 65 with modifiable risk factors. The study, conducted across 31 Australian practices, tested five nurse consultations alongside an action plan and the HAPPI MIND app; it assessed changes in risk scores, not whether participants developed dementia or avoided cognitive decline.
The study included more than 403 adults and compared the nurse-led program with standard care. Participants in the intervention group had five appointments with a nurse, received a personalized action plan and used an app designed for self-monitoring and goal tracking. The comparison group received their standard risk assessment results and educational material.
After 12 months, 56% of participants in the intervention group showed improvement, compared with 44% in the comparison group, according to the study report. Researchers said the intervention group’s gains were driven mainly by changes in protective lifestyle behaviors, including increased physical activity, improved fish intake and better body mass index status. The source does not provide the size of the average change in risk score.
The research was published in The Lancet Regional Health – Western Pacific. Senior author Associate Professor Johnson George, of Monash University’s Centre for Medicine Use and Safety, described the model as personalized support that helps people identify areas to work on and set practical targets. Lead author Dr Muhammad Rehan Sarwar said general practice may offer a way to support middle-aged adults in acting on risk factors relevant to brain health.
Primary Care as a Brain-Health Setting
The findings point to a way of delivering risk-reduction support through existing general practices, rather than relying only on people to interpret health information and make changes without follow-up. Regular nurse appointments and an app for tracking goals may give participants more structure as they work on several health behaviors at once. The trial offers evidence that this kind of support can shift estimated risk profiles over a year, though it does not establish that the program prevents dementia.
The distinction matters to patients and health services. Dementia risk scores and modifiable factors are not the same as a clinical diagnosis or a forecast of an individual’s future. Co-author Dr Amanda Cross said the trial measured changes in estimated profiles, not long-term diagnoses or cognitive decline. She also noted that some targeted factors may have nearer-term relevance to cardiovascular and metabolic health. The study report describes the program as a practical model for proactive brain-health support, but wider adoption would require further evaluation.
The Australian Institute of Health and Welfare estimates that 459,000 Australians are living with dementia in 2026 and projects the total will exceed one million by 2066. Those figures provide a public-health backdrop, not an outcome measured by this trial. The study’s immediate contribution is narrower: it tested whether personalized support in general practice could improve risk profiles among middle-aged adults with factors they may be able to address.
Popular right now
Samsung 48-Inch S90H OLED 4K Smart TV (2026)
Dyson V8 Cyclone Cordless Vacuum
Ninja Foodi 10-Quart DualZone 6-in-1 Air Fryer, Black, DZ302
As an affiliate, we earn on qualifying purchases.
How the Trial Tested the Program
The research focused on adults in midlife who had modifiable dementia risk factors. Rather than testing a drug or measuring dementia incidence, it evaluated a multi-domain program combining nurse consultations, an individualized plan and digital follow-up. Participants could use the HAPPI MIND app to monitor progress between appointments, while nurses helped translate guidance into personal goals.
The control group received standard risk assessment results and educational material, allowing researchers to compare outcomes with the additional nurse-led support. The 12-month study period captures changes within that year; it cannot show whether those changes continued afterward or affected later rates of cognitive decline. The work follows the publication of World Health Organization guidance on reducing risks for cognitive decline and dementia and a Monash-led update to Australia’s Clinical Practice Guidelines for Dementia, according to the source report.
“The trial measured changes in estimated risk profiles over 12 months, rather than tracking long term clinical diagnoses or preventing cognitive decline.”
— Dr Amanda Cross, co-author and senior research fellow
What the Twelve-Month Results Cannot Show
The study report does not establish whether participants who improved their risk profiles will maintain those changes, or whether the changes reduce future dementia diagnoses or cognitive decline. Those outcomes were not measured over the 12-month trial. The reported 56% and 44% figures show the share of participants whose profiles improved, but the source does not give the average score change, confidence intervals or enough detail here to assess the size of the difference.
It is also not clear from the source report how the program would perform if offered at a larger scale or in practices with different staffing and patient populations. The findings concern adults aged 45 to 65 with modifiable risk factors in Australian general practices; they should not be read as a guarantee of benefit for every person. Further follow-up and evaluation are needed before drawing conclusions about sustained effects or broader delivery.
Researchers Plan Longer Follow-Up
Researchers plan to examine 36-month follow-up data to see whether early improvements in estimated risk profiles persist. That analysis may clarify whether participants maintain changes in behaviors such as physical activity and diet after the initial year of consultations and app use. The source does not give a date for the follow-up results.
Sarwar said wider delivery could be considered if further evaluation supports it. Until then, the trial supports a limited conclusion: a nurse-led, app-supported program was associated with better estimated risk profiles over 12 months in the study group. The next evidence needed is whether those changes last and what, if any, longer-term health outcomes follow.
Key Questions
What did the Monash University study find?
In a trial across 31 Australian general practices, 56% of participants in the nurse-led program showed improved estimated dementia risk profiles after 12 months, compared with 44% in the comparison group.
What did participants receive?
Participants in the intervention received five nurse consultations, a personalized action plan and access to the HAPPI MIND app for self-monitoring and goal tracking. The comparison group received standard risk assessment results and educational material.
Does the study show that the program prevents dementia?
No. The trial measured changes in estimated risk profiles over 12 months. It did not track long-term dementia diagnoses or establish that the program prevents cognitive decline.
What happens next?
The researchers plan to review 36-month follow-up data to assess whether the early improvements last. The source report does not say when those results will be published.
Source: news-medical.net
